The European Medicines Agency (EMA) is giving recommendations on how to deal with a recall of some batches of the diabetes medicine NovoMix 30 FlexPen and Penfill. The affected batches are being ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback